A Phase II, MultiCenter, Randomized, Double-blind, Placebo-controlled Study of TAS-102 in Patients with Chemotherapy-Refractory Advanced Colorectal Cancer

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 14 Jan 2020

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

01 Jan 2020 Results of pos hoc analysis for substudy of RECOURSE (n=210) and phase II J003 (n=112) assesing pharmacokinetic data of Tipiracil/trifluridine exposure and pharmacodynamic markers such as chemotherapy induced neutropenia (CIN) and clinical outcomes, published in the Annals of Oncology.
21 Jan 2017 Results from this and other phase 3 trial presented at the 2017 Gastrointestinal Cancers Symposium
11 Oct 2016 Results reporting integrated safety summary for FTP/TPI using data from this and seven other trials presented at the 41st European Society for Medical Oncology Congress

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com